EvaluatePharma recently forecasted the 10 drugmakers that may have the highest worldwide prescription drug sales by 2026. Here are their predictions:
- Roche ($61 billion)
- Johnson & Johnson ($56.1 billion)
- Novartis ($54.8 billion)
- Merck & Co. ($53.2 billion)
- AbbVie ($52.7 billion)
- Pfizer ($51.1 billion)
- Bristol-Myers Squibb ($44.7 billion)
- Sanofi ($41.7 billion)
- AstraZeneca ($41 billion)
- GlaxoSmithKline ($40.8 billion)
More articles on pharmacy:
NIH updates remdesivir treatment guidelines
J&J to start human trials for COVID-19 vaccine this week
Growing number of polls find Americans hesitant about getting a future COVID-19 vaccine
